Sort   by:  
 Page size 
ProteomicsA Proteomic map of Leishmania donovani isolate from post kala-azar dermal leishmaniasis (PKDL) patient
In the present study, we carried out in-depth proteomic analysis of a clinical isolate of post kala-azar dermal leishmaniasis (PKDL) L. donovani promastigotes. The high-resolution mass spectrometry data was searched against protein database of L. donovani. This resulted in identification of 5, 283 u...
ORGANISM(S): Leishmania donovani Ld 2001 
2022-03-13 | PXD020541 | Pride
Kala-azar Kinetoplastids Phagolysosome Cutaneous leishmaniasis Intracellular parasite 
Unknown"Kala-Azar is a Dishonest Disease": Community Perspectives on Access Barriers to Visceral Leishmaniasis (Kala-Azar) Diagnosis and Care in Southern Gadarif, Sudan.
Not available
S-EPMC5928836 | biostudies-literature
UnknownIdentification of new antigens in visceral leishmaniasis by expression cloning and immunoblotting with sera of kala-azar patients from Bihar, India.
Not available
S-EPMC1230992 | biostudies-literature
ProteomicsProteomic map of the unsequenced kala-azar vector Phlebotomus papatasi
The debilitating disease kala-azar or visceral leishmaniasis (VL) is caused by the kinetoplastid protozoan parasite Leishmania donovani. The parasite is transmitted by the hematophagous sandfly vector of the genus Phlebotomus in the old world and Lutzomyia in the new world. The predominant Phlebotom...
ORGANISM(S): Phlebotomus papatasi (Sandfly) 
2015-08-31 | PXD002115 | Pride
Comparative proteogenomics Hematophagous arthropod and parasite vector 
UnknownDNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans.
Not available
S-EPMC387559 | biostudies-literature
Proteomics• Clinical proteomics profiling for biomarker identification among patients suffering with Indian Post Kala Azar Dermal Leishmaniasis
Post Kala Azar Dermal Leishmaniasis (PKDL) is a non-fatal dermal sequel of Visceral Leishmaniasis (VL), caused by protozoan parasite Leishmania donovani. On the global scenario, PKDL in mainly restricted to distinct zones of South Asia (India, Nepal and Bangladesh) and East Africa, mainly Sudan. In ...
ORGANISM(S): Homo sapiens (Human) 
2020-05-20 | PXD012960 | Pride
Cured (p4) Healthy (p1) Macular (p2) Post kala azar dermal leishmaniasis Circulating immune complexes Polymorphic (p3) Proteomics Biomarker 
Genomics
The role of non-coding RNA in kala-azar
PRJNA824834 | ENA
UnknownPost-kala-azar dermal leishmaniasis in the Indian subcontinent: A threat to the South-East Asia Region Kala-azar Elimination Programme.
Not available
S-EPMC5689828 | biostudies-literature
Genomics
The mechanism of action of noncoding RNA in kala-azar
PRJNA827265 | ENA
GenomicsPost Kala Azar Dermal Leishmaniasis (PKDL) genome wide transcriptional profiling by bulk RNA-sequencing
Post Kala Azar Dermal Leishmaniasis (PKDL) genome wide transcriptional profiling by bulk RNA-sequencing
PRJNA1436570 | ENA
Sort   by:  
 Page size